+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Codeine"

Codeine (CAS 76-57-3) Global Market Research Report 2024 - Product Thumbnail Image

Codeine (CAS 76-57-3) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
From
From
From
Analgesics Global Market Report 2024 - Product Thumbnail Image

Analgesics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Cough and Cold Preparations Global Market Report 2024 - Product Thumbnail Image

Cough and Cold Preparations Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Opioids Global Market Report 2024 - Product Thumbnail Image

Opioids Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
From
From
From
Conventional and Alternative Pain Treatment Markets - Product Thumbnail Image

Conventional and Alternative Pain Treatment Markets

  • Report
  • November 2020
  • 260 Pages
  • Global
From
Loading Indicator

Codeine is an opioid analgesic drug used to treat mild to moderate pain. It is derived from the opium poppy and is available in both prescription and over-the-counter forms. Codeine is often used in combination with other analgesics, such as acetaminophen or ibuprofen, to provide more effective pain relief. It is also used to treat coughs and diarrhea. Codeine is generally considered to be less potent than other opioids, such as morphine, and is therefore less likely to cause addiction or overdose. The codeine market is a subset of the larger analgesics market, which includes both prescription and over-the-counter drugs. The analgesics market is highly competitive, with a wide range of products available to consumers. The codeine market is also highly competitive, with a variety of products available from different manufacturers. Some of the companies in the codeine market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, and Novartis. Show Less Read more